Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 71335-9670

8 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 71335-9670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 01)

Image-1 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 01)
Chemical structure of Tramadol Hydrochloride, showing its molecular arrangement including methoxy, hydroxyl, and dimethylamino groups attached to a cyclohexane ring, with hydrochloride notation.*
FDA Label Image

Image-2 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 02)

Image-2 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 02)
A line graph depicting Tramadol concentration (ng/mL) over 24 hours comparing two formulations: Tramadol Hydrochloride Extended-Release Tablets, 200 mg once daily (q.d.) and Tramadol Hydrochloride Tablets, 50 mg every 6 hours (q6h). The y-axis shows concentration from 0 to 350 ng/mL, and the x-axis shows time in hours from 0 to 24.*
FDA Label Image

Image-3 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 03)

Image-3 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 03)
A line graph comparing M1 concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The horizontal axis shows time in hours, and the vertical axis displays M1 concentration. Two lines represent the different formulations' concentration profiles over time.*
FDA Label Image

Image-4 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 04)

Image-4 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 04)
A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of response thresholds (percent improvement from baseline). It compares response rates across four Tramadol Hydrochloride extended-release tablet doses (100 mg, 200 mg, 300 mg, and 400 mg) and a placebo group, with response percentage on the vertical axis and response threshold on the horizontal axis.*
FDA Label Image

Image-5 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 05)

Image-5 (251da4a2 F5b6 40c0 Ae16 C4dbc8212cc3 05)
This line graph illustrates the percent of patients achieving various response thresholds in a study on Tramadol Hydrochloride Extended-Release Tablets for arthritis pain intensity. The x-axis represents response thresholds as percent improvement from baseline, ranging from 0 to 100%. The y-axis shows the percent of patients achieving each response. Two lines compare Tramadol Hydrochloride Extended-Release Tablets and placebo, with the former showing consistently higher response rates across thresholds.*
FDA Label Image

Image (86731d11 21c5 43e2 A5df B96262c9ba5c 408 1)

Image (86731d11 21c5 43e2 A5df B96262c9ba5c 408 1)
The image shows a blister pack containing 10 extended-release tablets of Tramadol Hydrochloride 300 mg. The tablets are round, white, and arranged in two rows of five within a silver foil backing. No additional labeling or branding is visible on the blister pack itself.*
FDA Label Image

Image (86731d11 21c5 43e2 A5df B96262c9ba5c 393 1)

Image (86731d11 21c5 43e2 A5df B96262c9ba5c 393 1)
TRAMADOL HYDROCHLORIDE 300 mg Extended Release Oral Tablets package. The label is primarily white with black and red text. The front shows the product name, dosage strength, dosage form, and the labeler Bryant Ranch Prepack. The label includes standard prescription drug information areas and black markings on the edges.*
FDA Label Image

Label (Lbl713359670)

Label (Lbl713359670)
Label for TRAMADOL HYDROCHLORIDE Extended-Release Tablets USP 300 mg. The label includes the NDC 71335-9670-1 and indicates a package of 30 tablets. It shows the labeler as Bryant Ranch Prepack and the manufacturer as Lupin Limited. Storage instructions specify controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.